Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subhash G Vasudevan

Showing results (151-160 of 156) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 156 results.
Plos Pathogens|May 5, 2026
An orthoflavivirus inhibitor targeting multifunctional NS2A protein, a previously unidentified targetDoortje Borrenberghs, Kitti Wing Ki Chan, Sven Van Brandt, et al.
Nature Communications|March 14, 2018
A systematic approach to the development of a safe live attenuated Zika vaccineSwee Sen Kwek, Satoru Watanabe, Kuan Rong Chan, et al.
Journal of Medicinal Chemistry|December 18, 2009
N-sulfonylanthranilic acid derivatives as allosteric inhibitors of dengue viral RNA-dependent RNA polymeraseZheng Yin, Yen-Liang Chen, Ravinder Reddy Kondreddi, et al.
Plos Neglected Tropical Diseases|August 11, 2016
Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever PatientsCynthia Sung, Yuan Wei, Satoru Watanabe, et al.
The Lancet. Infectious Diseases|June 1, 2014
Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trialJenny G Low, Cynthia Sung, Limin Wijaya, et al.
Journal of Medicinal Chemistry|March 10, 2026
Sulfonyl Anthranilic Acid Analogues Display Pan-Serotype Anti-Dengue Activity by Downregulating the Expression of Ribosomal Proteins Encoded by 5'-Terminal Oligopyrimidine Motif-Containing mRNAChin Piaw Gwee, Tommaso Felicetti, Kitti Wing Ki Chan, et al.
Pageof 16

Showing results (151-160 of 156) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 156 results.
Plos Pathogens|May 5, 2026
An orthoflavivirus inhibitor targeting multifunctional NS2A protein, a previously unidentified targetDoortje Borrenberghs, Kitti Wing Ki Chan, Sven Van Brandt, et al.
Nature Communications|March 14, 2018
A systematic approach to the development of a safe live attenuated Zika vaccineSwee Sen Kwek, Satoru Watanabe, Kuan Rong Chan, et al.
Journal of Medicinal Chemistry|December 18, 2009
N-sulfonylanthranilic acid derivatives as allosteric inhibitors of dengue viral RNA-dependent RNA polymeraseZheng Yin, Yen-Liang Chen, Ravinder Reddy Kondreddi, et al.
Plos Neglected Tropical Diseases|August 11, 2016
Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever PatientsCynthia Sung, Yuan Wei, Satoru Watanabe, et al.
The Lancet. Infectious Diseases|June 1, 2014
Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trialJenny G Low, Cynthia Sung, Limin Wijaya, et al.
Journal of Medicinal Chemistry|March 10, 2026
Sulfonyl Anthranilic Acid Analogues Display Pan-Serotype Anti-Dengue Activity by Downregulating the Expression of Ribosomal Proteins Encoded by 5'-Terminal Oligopyrimidine Motif-Containing mRNAChin Piaw Gwee, Tommaso Felicetti, Kitti Wing Ki Chan, et al.
Pageof 16